Eris Lifesciences Limited
ERIS · ISIN: INE406M01024
Constituent of NIFTY 500 TRI (0.04%), NIFTY MC 150 TRI (0.15%), NIFTY SC 250 TRI (0.34%)
Earnings (TTM)
CHART
Eris Lifesciences Limited - revenue & profit (TTM)
Trailing-twelve-month figures by reported quarter, in ₹ Cr. Latest quarter: 2026-06-30.
26.28%
EBITDA Margin (TTM)
47.02
EPS (TTM)
11.59%
EPS Growth (5Y)
-
EPS Growth (10Y)
Technicals
44.81
RSI (14)
1382.41
SMA (50)
1415.02
SMA (200)
26.18
ADX (14)
1799
52-Week High
1200
52-Week Low
-25.2%
1Y Return
9.0774
Avg Traded Value (20D, ₹Cr)
As of 2026-09-08.
Shareholding Pattern
CHART
Shareholding by category
As of 2026-06-30.
Corporate Actions
No corporate actions on record for this stock.
Recent Deals
No recent block/bulk/short-sell deals on record for this stock.
Stock data · Not financial advice · Past performance does not indicate future returns